ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $83,421 | +30.3% | 5,240 | +33.1% | 0.00% | 0.0% |
| Q3 2022 | $64,000 | +68.4% | 3,937 | +45.3% | 0.00% | +100.0% |
| Q2 2022 | $38,000 | +153.3% | 2,709 | +328.6% | 0.00% | – |
| Q1 2022 | $15,000 | -72.7% | 632 | -70.4% | 0.00% | -100.0% |
| Q1 2021 | $55,000 | -92.3% | 2,133 | -83.9% | 0.00% | -93.9% |
| Q4 2020 | $710,000 | +5.5% | 13,277 | -18.7% | 0.03% | -13.2% |
| Q3 2020 | $673,000 | +1822.9% | 16,325 | +2139.4% | 0.04% | +533.3% |
| Q2 2020 | $35,000 | -5.4% | 729 | -17.6% | 0.01% | -70.0% |
| Q1 2020 | $37,000 | – | 885 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |